2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher
Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.
939 Views
Primer: Bloomage Biotechnology Lt (688363 CH) - Aug 2026
Bloomage Biotechnology is a global leader in hyaluronic acid (HA) raw materials, leveraging its vertically integrated model to expand into...
96 Views
Giant Biogene (2367 HK): Beaten Down Beauty. Valuation Upside After 40% Downslide
Powered by strong tailwinds - ingredient innovation and Guochao appeal, Biogene's functional beauty is well placed for growth. Recent sentiment-led...
620 Views
Giant Biogene Placement - Has Been Doing Well but Doesn’t Need the Cash
Giant Biogene (2367 HK) aims to raise up to US$205m via a top-up placement. In this note, we talk about the deal dynamics and run the deal through...
644 Views
A-Share Margin Trading Weekly (Jul 31st): ANHUI JIANGHUAI AUTOMOBILE, BLUEPARK NEW ENERGY TECHNOLOGY
We analyzed A-share margin trading positions report for the past week and highlighted ANHUI JIANGHUAI AUTOMOBILE (600418 CH), BLUEPARK NEW ENERGY...
141 Views